152 related articles for article (PubMed ID: 27997622)
1. Dexamethasone Chemotherapy Does Not Disrupt Orexin Signaling.
Kram DE; Krasnow SM; Levasseur PR; Zhu X; Stork LC; Marks DL
PLoS One; 2016; 11(12):e0168731. PubMed ID: 27997622
[TBL] [Abstract][Full Text] [Related]
2. The impact of maintenance therapy on sleep-wake rhythms and cancer-related fatigue in pediatric acute lymphoblastic leukemia.
Steur LMH; Kaspers GJL; van Someren EJW; van Eijkelenburg NKA; van der Sluis IM; Dors N; van den Bos C; Tissing WJE; Grootenhuis MA; van Litsenburg RRL
Support Care Cancer; 2020 Dec; 28(12):5983-5993. PubMed ID: 32285260
[TBL] [Abstract][Full Text] [Related]
3. A common neuronal mechanism of hypertension and sleep disturbances in spontaneously hypertensive rats: Role of orexinergic neurons.
Cui SY; Huang YL; Cui XY; Zhao HL; Hu X; Liu YT; Qin Y; Kurban N; Zhang YH
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109902. PubMed ID: 32109507
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia.
Hinds PS; Hockenberry MJ; Gattuso JS; Srivastava DK; Tong X; Jones H; West N; McCarthy KS; Sadeh A; Ash M; Fernandez C; Pui CH
Cancer; 2007 Nov; 110(10):2321-30. PubMed ID: 17926333
[TBL] [Abstract][Full Text] [Related]
5. The impact of dexamethasone and prednisone on sleep in children with acute lymphoblastic leukemia.
Daniel LC; Li Y; Kloss JD; Reilly AF; Barakat LP
Support Care Cancer; 2016 Sep; 24(9):3897-906. PubMed ID: 27108263
[TBL] [Abstract][Full Text] [Related]
6. The effects of dexamethasone on sleep in young children with acute lymphoblastic leukemia.
Rosen G; Harris AK; Liu M; Dreyfus J; Krueger J; Messinger YH
Sleep Med; 2015 Apr; 16(4):503-9. PubMed ID: 25799940
[TBL] [Abstract][Full Text] [Related]
7. Effects of Sleep Deprivation (SD) on Rats via ERK1/2 Signaling Pathway.
Wang L; Gu Y; Zhang J; Gong L
Med Sci Monit; 2019 Apr; 25():2886-2895. PubMed ID: 31002658
[TBL] [Abstract][Full Text] [Related]
8. Sleep disorders, obesity, and aging: the role of orexin.
Nixon JP; Mavanji V; Butterick TA; Billington CJ; Kotz CM; Teske JA
Ageing Res Rev; 2015 Mar; 20():63-73. PubMed ID: 25462194
[TBL] [Abstract][Full Text] [Related]
9. Recent trends in orexin research--2010 to 2015.
Boss C; Roch C
Bioorg Med Chem Lett; 2015 Aug; 25(15):2875-87. PubMed ID: 26045032
[TBL] [Abstract][Full Text] [Related]
10. Hypothalamic orexin and mechanistic target of rapamycin activation mediate sleep dysfunction in a mouse model of tuberous sclerosis complex.
Zhang B; Guo D; Han L; Rensing N; Satoh A; Wong M
Neurobiol Dis; 2020 Feb; 134():104615. PubMed ID: 31605778
[TBL] [Abstract][Full Text] [Related]
11. Intermittent Short Sleep Results in Lasting Sleep Wake Disturbances and Degeneration of Locus Coeruleus and Orexinergic Neurons.
Zhu Y; Fenik P; Zhan G; Somach R; Xin R; Veasey S
Sleep; 2016 Aug; 39(8):1601-11. PubMed ID: 27306266
[TBL] [Abstract][Full Text] [Related]
12. Sleep deprivation-induced pre- and postsynaptic modulation of orexin neurons.
Briggs C; Bowes SC; Semba K; Hirasawa M
Neuropharmacology; 2019 Aug; 154():50-60. PubMed ID: 30586566
[TBL] [Abstract][Full Text] [Related]
13. Expression of the M3 Muscarinic Receptor on Orexin Neurons that Project to the Rostral Ventrolateral Medulla.
Dai YW; Lee YH; Chen JY; Lin YK; Hwang LL
Anat Rec (Hoboken); 2016 May; 299(5):660-8. PubMed ID: 26910770
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor I modulates sleep through hypothalamic orexin neurons.
Zegarra-Valdivia JA; Pignatelli J; Fernandez de Sevilla ME; Fernandez AM; Munive V; Martinez-Rachadell L; Nuñez A; Torres Aleman I
FASEB J; 2020 Dec; 34(12):15975-15990. PubMed ID: 33070417
[TBL] [Abstract][Full Text] [Related]
15. Chronopathophysiological implications of orexin in sleep disturbances and lifestyle-related disorders.
Tsuneki H; Wada T; Sasaoka T
Pharmacol Ther; 2018 Jun; 186():25-44. PubMed ID: 29289556
[TBL] [Abstract][Full Text] [Related]
16. Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children's Oncology Group.
Dupuis LL; Lu X; Mitchell HR; Sung L; Devidas M; Mattano LA; Carroll WL; Winick N; Hunger SP; Maloney KW; Kadan-Lottick NS
Cancer; 2016 Apr; 122(7):1116-25. PubMed ID: 26773735
[TBL] [Abstract][Full Text] [Related]
17. Orexins (hypocretins) directly interact with neuropeptide Y, POMC and glucose-responsive neurons to regulate Ca 2+ signaling in a reciprocal manner to leptin: orexigenic neuronal pathways in the mediobasal hypothalamus.
Muroya S; Funahashi H; Yamanaka A; Kohno D; Uramura K; Nambu T; Shibahara M; Kuramochi M; Takigawa M; Yanagisawa M; Sakurai T; Shioda S; Yada T
Eur J Neurosci; 2004 Mar; 19(6):1524-34. PubMed ID: 15066149
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of dexamethasone-induced disturbed sleep and fatigue in paediatric patients receiving treatment for ALL.
Vallance K; Liu W; Mandrell BN; Panetta JC; Gattuso JS; Hockenberry M; Zupanec S; Yang L; Yang J; Hinds PS
Eur J Cancer; 2010 Jul; 46(10):1848-55. PubMed ID: 20400291
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic orexin's role in exacerbated cutaneous vasodilation responses to an anxiogenic stimulus in a surgical menopause model.
Federici LM; Caliman IF; Molosh AI; Fitz SD; Truitt WA; Bonaventure P; Carpenter JS; Shekhar A; Johnson PL
Psychoneuroendocrinology; 2016 Mar; 65():127-37. PubMed ID: 26765933
[TBL] [Abstract][Full Text] [Related]
20. Parental functioning during maintenance treatment for childhood acute lymphoblastic leukemia: Effects of treatment intensity and dexamethasone pulses.
Rensen N; Steur LMH; Grootenhuis MA; van Eijkelenburg NKA; van der Sluis IM; Dors N; van den Bos C; Tissing WJE; Kaspers GJL; van Litsenburg RRL
Pediatr Blood Cancer; 2020 Nov; 67(11):e28697. PubMed ID: 32909677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
